Target
IFNA2 / Interferon Alpha 2
Synonyms
IFNA2 | Alpha-2a interferon | IFNA | IFN-alphaA | Interferon alpha 2b | Interferon alpha A | Interferon alpha-A | INFA2 | Interferon alpha 2a | LeIF A | IFNA2B | IFN-alpha-2 | Interferon alpha-2 | Interferon, alpha 2
Modifications
Carrier-free
Conjugations
Unconjugated
Predicted Molecular Weight
The 166 amino acid recombinant protein has a predicted molecular mass of approximately 19.4 kD. The DTT-reduced and non-reduced proteins migrate at approximately 20 kD and 18 kD respectively by SDS-PAGE. The N-terminal amino acid is Met.
Purification
Greater than 95% by SDS-PAGE
Usage Summary
Stock solutions should be prepared at no less than 10 µg/mL in sterile buffer (PBS, HPBS, DPBS, and EBSS) containing carrier protein such as 1% BSA or HSA.
Bio-Activity
Recombinant human IFN-a2 induces CCL2 (MCP-1) production in U937 cells in a dose dependent manner. The ED50 of this effect is 0.02-0.14 ng/mL.
Endotoxin
Less than 0.01 ng/µg (determined by LAL method).
Presentation
0.22 µm filtered protein solution in PBS, pH 7.2
Storage
Store unopened at 2°C to 8°C for up to 3 months, at -20°C for up to 6 months, or at -70°C for up to 1 year. Store diluted at 2°C to 8°C for up to 1 month, or at -20°to -70°C for up to 3 months. Avoid freeze/thaw cycles. For maximum results, quick spin vial prior to opening.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This protein carries the LSBio 100% Guarantee.
LSBio Guarantee
About IFNA2 / Interferon Alpha 2